These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 22354924)
1. Challenges for a universal Staphylococcus aureus vaccine. Proctor RA Clin Infect Dis; 2012 Apr; 54(8):1179-86. PubMed ID: 22354924 [TBL] [Abstract][Full Text] [Related]
2. Is there a future for a Staphylococcus aureus vaccine? Proctor RA Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633 [TBL] [Abstract][Full Text] [Related]
3. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage. Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513 [TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus antigens and challenges in vaccine development. Middleton JR Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778 [TBL] [Abstract][Full Text] [Related]
5. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. Mancini F; Monaci E; Lofano G; Torre A; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Galletti B; Laera D; Pallaoro M; Tuscano G; Fontana MR; Bensi G; Grandi G; Rossi-Paccani S; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Soldaini E; Bertholet S PLoS One; 2016; 11(1):e0147767. PubMed ID: 26812180 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection. Narita K; Hu DL; Asano K; Nakane A Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736 [TBL] [Abstract][Full Text] [Related]
7. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines. Broughan J; Anderson R; Anderson AS Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989 [TBL] [Abstract][Full Text] [Related]
8. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model. Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117 [TBL] [Abstract][Full Text] [Related]
9. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice. Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921 [TBL] [Abstract][Full Text] [Related]
10. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus. Moscoso M; García P; Cabral MP; Rumbo C; Bou G Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750 [TBL] [Abstract][Full Text] [Related]
11. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms. Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ mBio; 2018 Oct; 9(5):. PubMed ID: 30327437 [No Abstract] [Full Text] [Related]
12. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection. Narita K; Hu DL; Asano K; Nakane A Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568 [TBL] [Abstract][Full Text] [Related]
13. CD40 triggering induces strong cytotoxic T lymphocyte responses to heat-killed Staphylococcus aureus immunization in mice: a new vaccine strategy for staphylococcal mastitis. Wallemacq H; Bedoret D; Pujol J; Desmet C; Drion PV; Farnir F; Mainil J; Lekeux P; Bureau F; Fiévez L Vaccine; 2012 Mar; 30(12):2116-24. PubMed ID: 22285272 [TBL] [Abstract][Full Text] [Related]
14. Prospects for active and passive immunization against Staphylococcus aureus. Shinefield HR; Black S Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297 [No Abstract] [Full Text] [Related]
15. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC; Lee JC Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic strategies to combat staphylococcal infections. Ohlsen K; Lorenz U Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101 [TBL] [Abstract][Full Text] [Related]
17. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein. Therrien R; Lacasse P; Grondin G; Talbot BG Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546 [TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. Mishra RP; Mariotti P; Fiaschi L; Nosari S; Maccari S; Liberatori S; Fontana MR; Pezzicoli A; De Falco MG; Falugi F; Altindis E; Serruto D; Grandi G; Bagnoli F J Infect Dis; 2012 Oct; 206(7):1041-9. PubMed ID: 22829645 [TBL] [Abstract][Full Text] [Related]